Betnovate
Formulated to alleviate inflammatory skin conditions like eczema and psoriasis, indicated to target localized skin redness and itching, effective for managing acute dermatological flares.
Strengths: 0.1%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Diprolene; Diprosone; Celestoderm
- Therapeutic class
Corticosteroid
- Pharmacological class
Topical Corticosteroid
- Contraindications
rosacea; acne vulgaris; perioral dermatitis
- Precautions and warnings
avoid prolonged use on face; avoid contact with eyes
- Minor side effects
local irritation; skin thinning
- Moderate side effects
striae; telangiectasia
- Serious side effects
adrenal suppression — requires immediate medical attention
- Dosage forms
Cream
- Administration route
Cutaneous use
- Prescription status
POM
- Manufacturer
GlaxoSmithKline
- Onset Time
days
- Duration
daily
- Storage instructions
Store below 25°C, away from direct heat.
- Age restrictions
Use with caution in children.
Patient summary
Formulated to alleviate inflammatory skin conditions like eczema and psoriasis, indicated to target localized skin redness and itching, effective for managing acute dermatological flares.
Mechanism of action
Betamethasone acts as a potent anti-inflammatory agent, binding to glucocorticoid receptors to inhibit the synthesis of inflammatory mediators in the skin.
Pregnancy and breastfeeding
Pregnancy: Use small amounts for short periods only. Breastfeeding: Safe if applied to limited areas.
Betnovate
Formulated to alleviate inflammatory skin conditions like eczema and psoriasis, indicated to target localized skin redness and itching, effective for managing acute dermatological flares.
Editorial Notes
- Active ingredient(s): Betamethasone
- Listed indication(s): Eczema, Psoriasis, Dermatitis